Cancer survival rates are usually discussed in terms of 5-year relative survival, which refers to the proportion of patients still alive 5 years after diagnosis. Keep in mind that statistics like these are based on large groups of people and cannot predict what might happen with an individual patient.
In the United States, the overall, the five-year survival rate for women with invasive cervical cancer is about 68%. However, these statistics do not include the large number of women diagnosed with precancers, far more common and easier to treat successfully than invasive cervical cancer. Routine screening with Pap and/or HPV testing can detect these precancers, providing important opportunity to treat the precancer and avoid progression to invasive cancer.
Survival is largely dependent on the cancer’s stage at the time of diagnosis, and data from the National Cancer Institute shows these survival rates for cervical cancer:
Stage of disease at diagnosis | Five-year survival rate |
|---|---|
Localized disease (such as Stage 1) where the cancer was confined to the original location. | 91.4% |
Regional disease (such as stage 2 and 3) where the disease has spread to nearby lymph nodes | 62.3% |
Distant disease (stage 4) where the cancer has already spread to other body areas | 19.5% |
How Roswell Park optimizes your survival
As a national leader in cancer care, Roswell Park’s approach includes several components that maximize survival and quality of life, including:
- High-volume expertise in complex gynecologic surgery
- Clinical trials of the latest approaches, new drugs and immunotherapy
- Young Adult program that integrates key supportive services especially for young adult patients in their 20s and 30s.
You have time for a second opinion
A precise and accurate diagnosis, staging, and treatment plan by a team of experts who focus on cervical cancer every day. If you have been diagnosed with cervical cancer, you need a second opinion. We will ensure you get it without delay.